Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis

Kevin Phan*, Nelson Wang, Laurent Pison, Narendra Kumar, Kerry Hitos, Stuart P. Thomas

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Web of Science)
Original languageEnglish
Pages (from-to)209-213
JournalInternational Journal of Cardiology
Volume185
DOIs
Publication statusPublished - 15 Apr 2015

Keywords

  • Ablation
  • Dabigatran
  • Warfarin
  • Rivaroxaban
  • Thromboembolism
  • VKA

Cite this